It's been an eventful year for Alnylam. A 16-year-long research project into RNA interference resulted in approval of Onpattro, the biotech's first commercial product and a landmark for the technology's development.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,